Abstract
Summary COVID-19 had a mild clinical course in patients with Agammaglobulinemia lacking B lymphocytes, whereas it developed aggressively in Common Variable Immune Deficiency. Our data offer mechanisms for possible therapeutic targets.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have